Unspecified Adult Solid Tumor, Protocol Specific — Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
Citation(s)
A Phase I Study of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib; Tarceva) in Advanced Solid Tumors